BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries North America

AbbVie To Acquire Gilgamesh’s Lead Psychedelic Compound Bretisilocin For Up To $1.2 Billion

Gilgamesh's lead asset, bretisilocin (GM-2505), is a potential best-in-class psychedelic compound currently in Phase 2 development for the treatment of m...

August 26, 2025 | News

Esaote’s MyLab™ A50 and MyLab™ A70 Ultrasound Systems Achieve FDA Approval

Esaote – one of the world's leading medical imaging companies - is proud to announce that the MyLab™ A50 and MyLab™ A...

August 25, 2025 | News

Lighthouse Pharma Secures $49.2M NIH Grant to Launch Phase 2 Alzheimer’s Trial in the United States

Groundbreaking Clinical Trial to Enroll 300 Patients in Double-Blind, Placebo-Controlled Study of Lysine-Gingipain Inhibitor Lighthouse Pharmaceuticals, a...

August 25, 2025 | News

Piramal Pharma Solutions and NewAmsterdam Pharma Expand Global OSD Manufacturing with Facilities in USA and India

Piramal Pharma Solutions, a global leader in contract development and manufacturing (CDMO) and part of Piramal Pharma Ltd. (NSE: PPLPHARMA) (BSE: 543635), ...

August 25, 2025 | News

Thermo Fisher Expands U.S. Footprint with New $192.5M Manufacturing Center in North Carolina

Thermo Fisher Scientific Inc., the world leader in serving science, announced the grand opening of its innovative manufacturing center of excellence ...

August 22, 2025 | News

Andelyn Biosciences Partners with Amplo Biotechnology to Advance AAV Gene Therapies for NMJ Disorders

Andelyn Biosciences, Inc., a leading and patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered wi...

August 22, 2025 | News

XtalPi and Dong-A ST Sign MOU to Accelerate AI-Driven Drug Discovery in Immunology and Inflammation

XtalPi announced on the 20th that it signed a Memorandum of Understanding (MOU) with Korea's leading pharmaceutical company Dong-A ST, to jointl...

August 21, 2025 | News

Ginkgo Bioworks Partners with Inductive Bio and Tangible Scientific to Deliver AI-Driven Lab-in-the-Loop Drug Discovery

Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, announced that its Datapoints offering ...

August 21, 2025 | News

Somite.ai Secures Strategic Investment from AMD Ventures to Advance Foundation Models for Cell Therapy

Somite.ai, a company pioneering foundation models for human stem cells, announced a strategic investment from AMD Ventures, following Somite's $...

August 21, 2025 | News

Thermo Fisher Launches Gibco™ Expi293™ PRO System to Transform Protein Expression

Thermo Fisher Scientific has introduced the Gibco™ Expi293™ PRO Expression System, a next-generation HEK293 transient expression system designe...

August 20, 2025 | News

LabConnect Launches LabConnector™ to Transform Clinical Trial Data Management

LabConnect, LLC, a global leader in central laboratory services for clinical trials, announced the launch of LabConnector™, a powerful new techn...

August 20, 2025 | News

South Korea’s Avixgen, Subsidiary of Dx&Vx, Signs $360M Licensing-Out Deal with U.S. Biotech for ACP Drug Delivery Platform

This innovative platform technology, with exceptional scalability, has been recognized as highly valuable even with limited rights granted. DXVX is taki...

August 19, 2025 | News

Anixa Biosciences Advances Phase 1 Trial of FSHR-Targeted CAR-T Therapy for Recurrent Ovarian Cancer

Anixa Biosciences, Inc. a biotechnology company focused on the treatment and prevention of cancer, announced that the second patient in th...

August 19, 2025 | News

Novo Nordisk Expands U.S. Access to FDA-Approved Ozempic® with $499 Monthly Offer for Uninsured Patients

Offer supports access for eligible patients without insurance to FDA-approved Ozempic® (semaglutide) injection 0.5 mg, 1 mg,...

August 19, 2025 | News

Stay Connected